Cargando…
Therapeutic efficacy of a four-year treatment with eribulin in a patient with uterine leiomyosarcoma: A case report
Uterine leiomyosarcoma (LMS) is a gynecological malignancy with an extremely poor prognosis. Multiple new therapeutic agents, including pazopanib, trabectedin, and eribulin, have been clinically applied to treat uterine LMS, and their therapeutic effects are expected. We encountered one patient with...
Autores principales: | Matsuura, Motoki, Yorozu, Kazuma, Nagao, Sachiko, Kurokawa, Shoko, Tamate, Masato, Akimoto, Taishi, Saito, Tsuyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238571/ https://www.ncbi.nlm.nih.gov/pubmed/37273765 http://dx.doi.org/10.1016/j.gore.2023.101205 |
Ejemplares similares
-
Mucinous carcinoma originating in the peritoneum diagnosed by an ascites cell block: a case report
por: Nagao, Sachiko, et al.
Publicado: (2020) -
Preclinical activity of selinexor in combination with eribulin in uterine leiomyosarcoma
por: Mittal, Sonam, et al.
Publicado: (2023) -
Cervical conization with endoCUT mode applying gastrointestinal endoscopic polypectomy technique
por: Tamate, Masato, et al.
Publicado: (2023) -
Mailing human papillomavirus self-sampling kits to women under-screened for cervical cancer improved detection in cervical cancer screening in a general population study in Japan
por: Nishimura, Yoko, et al.
Publicado: (2023) -
Radical Vaginal Trachelectomy
por: Saito, Tsuyoshi, et al.
Publicado: (2021)